ID   SIG10_HUMAN             Reviewed;         697 AA.
AC   Q96LC7; A8K1I5; A8K3C7; C9JJ33; C9JM10; F8W917; Q3MIR5; Q6UXI8; Q96G54;
AC   Q96LC8;
DT   08-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 3.
DT   03-AUG-2022, entry version 192.
DE   RecName: Full=Sialic acid-binding Ig-like lectin 10;
DE            Short=Siglec-10;
DE   AltName: Full=Siglec-like protein 2;
DE   Flags: Precursor;
GN   Name=SIGLEC10; Synonyms=SLG2; ORFNames=UNQ477/PRO940;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 2).
RX   PubMed=11409878; DOI=10.1006/bbrc.2001.5053;
RA   Yousef G.M., Ordon M.H., Foussias G., Diamandis E.P.;
RT   "Molecular characterization, tissue expression, and mapping of a novel
RT   Siglec-like gene (SLG2) with three splice variants.";
RL   Biochem. Biophys. Res. Commun. 284:900-910(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, AND
RP   VARIANT VAL-226.
RC   TISSUE=Spleen;
RX   PubMed=11284738; DOI=10.1042/0264-6021:3550489;
RA   Munday J., Kerr S., Ni J., Cornish A.L., Zhang J.Q., Nicoll G., Floyd H.,
RA   Mattei M.-G., Moore P., Liu D., Crocker P.R.;
RT   "Identification, characterization and leucocyte expression of Siglec-10, a
RT   novel human sialic acid-binding receptor.";
RL   Biochem. J. 355:489-497(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND VARIANT
RP   VAL-226.
RC   TISSUE=Dendritic cell;
RX   PubMed=11358961; DOI=10.1074/jbc.m100467200;
RA   Li N., Zhang W., Wan T., Zhang J., Chen T., Yu Y., Wang J., Cao X.;
RT   "Cloning and characterization of Siglec-10, a novel sialic acid binding
RT   member of the Ig superfamily, from human dendritic cells.";
RL   J. Biol. Chem. 276:28106-28112(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), ALTERNATIVE SPLICING (ISOFORMS 4
RP   AND 5), TISSUE SPECIFICITY, VARIANT VAL-226, PHOSPHORYLATION AT TYR-667,
RP   MUTAGENESIS OF TYR-667, INTERACTION WITH PTPN6, AND FUNCTION.
RX   PubMed=12163025; DOI=10.1016/s0006-291x(02)00885-9;
RA   Kitzig F., Martinez-Barriocanal A., Lopez-Botet M., Sayos J.;
RT   "Cloning of two new splice variants of Siglec-10 and mapping of the
RT   interaction between Siglec-10 and SHP-1.";
RL   Biochem. Biophys. Res. Commun. 296:355-362(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 6 AND 7), AND VARIANT
RP   VAL-226.
RC   TISSUE=Brain, and Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT VAL-226.
RC   TISSUE=B-cell, and Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH CD24 AND HMGB1, AND MUTAGENESIS OF ARG-119.
RX   PubMed=19264983; DOI=10.1126/science.1168988;
RA   Chen G.Y., Tang J., Zheng P., Liu Y.;
RT   "CD24 and Siglec-10 selectively repress tissue damage-induced immune
RT   responses.";
RL   Science 323:1722-1725(2009).
RN   [10]
RP   FUNCTION.
RX   PubMed=25450598; DOI=10.1016/j.jss.2014.09.035;
RA   Zhang P., Lu X., Tao K., Shi L., Li W., Wang G., Wu K.;
RT   "Siglec-10 is associated with survival and natural killer cell dysfunction
RT   in hepatocellular carcinoma.";
RL   J. Surg. Res. 194:107-113(2015).
CC   -!- FUNCTION: Putative adhesion molecule that mediates sialic-acid
CC       dependent binding to cells. Preferentially binds to alpha-2,3- or
CC       alpha-2,6-linked sialic acid (By similarity). The sialic acid
CC       recognition site may be masked by cis interactions with sialic acids on
CC       the same cell surface. In the immune response, seems to act as an
CC       inhibitory receptor upon ligand induced tyrosine phosphorylation by
CC       recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that
CC       block signal transduction through dephosphorylation of signaling
CC       molecules (PubMed:11284738, PubMed:12163025). Involved in negative
CC       regulation of B-cell antigen receptor signaling. The inhibition of B
CC       cell activation is dependent on PTPN6/SHP-1 (By similarity). In
CC       association with CD24 may be involved in the selective suppression of
CC       the immune response to danger-associated molecular patterns (DAMPs)
CC       such as HMGB1, HSP70 and HSP90 (By similarity). In association with
CC       CD24 may regulate the immune repsonse of natural killer (NK) cells
CC       (PubMed:25450598). Plays a role in the control of autoimmunity (By
CC       similarity). During initiation of adaptive immune responses by CD8-
CC       alpha(+) dendritic cells inhibits cross-presentation by impairing the
CC       formation of MHC class I-peptide complexes. The function seems to
CC       implicate recruitment of PTPN6/SHP-1, which dephosphorylates NCF1 of
CC       the NADPH oxidase complex consequently promoting phagosomal
CC       acidification (By similarity). {ECO:0000250|UniProtKB:Q80ZE3,
CC       ECO:0000269|PubMed:11284738, ECO:0000269|PubMed:25450598,
CC       ECO:0000305|PubMed:12163025}.
CC   -!- SUBUNIT: Interacts with PTPN6/SHP-1 upon phosphorylation
CC       (PubMed:12163025). Interacts with NCF1 (By similarity). Interacts with
CC       CD24; the probable CD24:SIGLEC10 complex is proposed to inhibit HGMB1-
CC       mediated tissue damage immune response. Interacts with HMGB1; the
CC       interaction is dependent on CD24 (PubMed:19264983). Interacts with
CC       DDX58, CBL and PTPN11 (By similarity). {ECO:0000250|UniProtKB:Q80ZE3,
CC       ECO:0000269|PubMed:12163025, ECO:0000269|PubMed:19264983}.
CC   -!- INTERACTION:
CC       Q96LC7; P0DTC2: S; Xeno; NbExp=2; IntAct=EBI-8502656, EBI-25474821;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cell membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cell membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Cell membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 5]: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=9;
CC       Name=1; Synonyms=Long;
CC         IsoId=Q96LC7-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short, Sv1;
CC         IsoId=Q96LC7-2; Sequence=VSP_002565;
CC       Name=3; Synonyms=Sv3;
CC         IsoId=Q96LC7-3; Sequence=VSP_002564;
CC       Name=4; Synonyms=Sv4;
CC         IsoId=Q96LC7-4; Sequence=VSP_002561;
CC       Name=5; Synonyms=Sv2;
CC         IsoId=Q96LC7-5; Sequence=VSP_002562, VSP_002563;
CC       Name=6;
CC         IsoId=Q96LC7-6; Sequence=VSP_002564, VSP_002565;
CC       Name=7;
CC         IsoId=Q96LC7-7; Sequence=VSP_045365, VSP_002565;
CC       Name=8;
CC         IsoId=Q96LC7-8; Sequence=VSP_002564, VSP_045853, VSP_045854,
CC                                  VSP_002565;
CC       Name=9;
CC         IsoId=Q96LC7-9; Sequence=VSP_045888, VSP_002565;
CC   -!- TISSUE SPECIFICITY: Expressed by peripheral blood leukocytes
CC       (eosinophils, monocytes and a natural killer cell subpopulation).
CC       Isoform 5 is found to be the most abundant isoform. Found in lymph
CC       node, lung, ovary and appendix. Isoform 1 is found at high levels and
CC       isoform 2 at lower levels in bone marrow, spleen and spinal chord.
CC       Isoform 2 is also found in brain. Isoform 4 is specifically found in
CC       natural killer cells. {ECO:0000269|PubMed:11284738,
CC       ECO:0000269|PubMed:11358961, ECO:0000269|PubMed:12163025}.
CC   -!- DOMAIN: Contains 1 copy of a cytoplasmic motif that is referred to as
CC       the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is
CC       involved in modulation of cellular responses. The phosphorylated ITIM
CC       motif can bind the SH2 domain of several SH2-containing phosphatases.
CC   -!- PTM: Phosphorylation of Tyr-667 is involved in binding to PTPN6.
CC       {ECO:0000269|PubMed:12163025}.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. SIGLEC (sialic
CC       acid binding Ig-like lectin) family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Siglec-10 [5 Fc Domains];
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Itlect_00002";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Siglec-10 long;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Itlect_268";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY029277; AAK40255.1; -; Genomic_DNA.
DR   EMBL; AY029277; AAK40256.1; -; Genomic_DNA.
DR   EMBL; AF310233; AAK55139.1; -; mRNA.
DR   EMBL; AF311905; AAK92542.1; -; mRNA.
DR   EMBL; AY032685; AAK51124.1; -; mRNA.
DR   EMBL; AY358337; AAQ88703.1; -; mRNA.
DR   EMBL; AK289900; BAF82589.1; -; mRNA.
DR   EMBL; AK290542; BAF83231.1; -; mRNA.
DR   EMBL; AK303514; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC008750; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC009955; AAH09955.2; -; mRNA.
DR   EMBL; BC101725; AAI01726.1; -; mRNA.
DR   CCDS; CCDS12832.1; -. [Q96LC7-1]
DR   CCDS; CCDS54301.1; -. [Q96LC7-8]
DR   CCDS; CCDS54302.1; -. [Q96LC7-6]
DR   CCDS; CCDS54303.1; -. [Q96LC7-3]
DR   CCDS; CCDS54304.1; -. [Q96LC7-7]
DR   CCDS; CCDS54305.1; -. [Q96LC7-2]
DR   RefSeq; NP_001164627.1; NM_001171156.1. [Q96LC7-3]
DR   RefSeq; NP_001164628.1; NM_001171157.1. [Q96LC7-2]
DR   RefSeq; NP_001164629.1; NM_001171158.1. [Q96LC7-7]
DR   RefSeq; NP_001164630.1; NM_001171159.1. [Q96LC7-6]
DR   RefSeq; NP_001164632.1; NM_001171161.1. [Q96LC7-8]
DR   RefSeq; NP_001309034.1; NM_001322105.1.
DR   RefSeq; NP_149121.2; NM_033130.4. [Q96LC7-1]
DR   AlphaFoldDB; Q96LC7; -.
DR   SMR; Q96LC7; -.
DR   BioGRID; 124602; 22.
DR   IntAct; Q96LC7; 11.
DR   MINT; Q96LC7; -.
DR   STRING; 9606.ENSP00000345243; -.
DR   ChEMBL; CHEMBL4303061; -.
DR   GlyGen; Q96LC7; 6 sites.
DR   iPTMnet; Q96LC7; -.
DR   PhosphoSitePlus; Q96LC7; -.
DR   BioMuta; SIGLEC10; -.
DR   DMDM; 118572721; -.
DR   EPD; Q96LC7; -.
DR   jPOST; Q96LC7; -.
DR   MassIVE; Q96LC7; -.
DR   MaxQB; Q96LC7; -.
DR   PaxDb; Q96LC7; -.
DR   PeptideAtlas; Q96LC7; -.
DR   PRIDE; Q96LC7; -.
DR   ProteomicsDB; 10427; -.
DR   ProteomicsDB; 10785; -.
DR   ProteomicsDB; 30242; -.
DR   ProteomicsDB; 77195; -. [Q96LC7-1]
DR   ProteomicsDB; 77196; -. [Q96LC7-2]
DR   ProteomicsDB; 77197; -. [Q96LC7-3]
DR   ProteomicsDB; 77198; -. [Q96LC7-4]
DR   ProteomicsDB; 77199; -. [Q96LC7-5]
DR   ProteomicsDB; 77200; -. [Q96LC7-6]
DR   Antibodypedia; 19024; 312 antibodies from 27 providers.
DR   DNASU; 89790; -.
DR   Ensembl; ENST00000339313.10; ENSP00000345243.4; ENSG00000142512.15. [Q96LC7-1]
DR   Ensembl; ENST00000353836.9; ENSP00000342389.5; ENSG00000142512.15. [Q96LC7-2]
DR   Ensembl; ENST00000436984.6; ENSP00000414324.2; ENSG00000142512.15. [Q96LC7-7]
DR   Ensembl; ENST00000439889.6; ENSP00000389132.2; ENSG00000142512.15. [Q96LC7-3]
DR   Ensembl; ENST00000441969.7; ENSP00000408387.2; ENSG00000142512.15. [Q96LC7-6]
DR   Ensembl; ENST00000442846.7; ENSP00000395475.2; ENSG00000142512.15. [Q96LC7-8]
DR   GeneID; 89790; -.
DR   KEGG; hsa:89790; -.
DR   MANE-Select; ENST00000339313.10; ENSP00000345243.4; NM_033130.5; NP_149121.2.
DR   UCSC; uc002pwo.4; human. [Q96LC7-1]
DR   CTD; 89790; -.
DR   DisGeNET; 89790; -.
DR   GeneCards; SIGLEC10; -.
DR   HGNC; HGNC:15620; SIGLEC10.
DR   HPA; ENSG00000142512; Tissue enhanced (lymphoid).
DR   MIM; 606091; gene.
DR   neXtProt; NX_Q96LC7; -.
DR   OpenTargets; ENSG00000142512; -.
DR   PharmGKB; PA38004; -.
DR   VEuPathDB; HostDB:ENSG00000142512; -.
DR   eggNOG; ENOG502S41V; Eukaryota.
DR   GeneTree; ENSGT01040000240469; -.
DR   HOGENOM; CLU_024444_5_1_1; -.
DR   InParanoid; Q96LC7; -.
DR   OMA; CEAWNTH; -.
DR   OrthoDB; 1124645at2759; -.
DR   PhylomeDB; Q96LC7; -.
DR   TreeFam; TF332441; -.
DR   PathwayCommons; Q96LC7; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   SignaLink; Q96LC7; -.
DR   SIGNOR; Q96LC7; -.
DR   BioGRID-ORCS; 89790; 11 hits in 1065 CRISPR screens.
DR   ChiTaRS; SIGLEC10; human.
DR   GeneWiki; SIGLEC10; -.
DR   GenomeRNAi; 89790; -.
DR   Pharos; Q96LC7; Tbio.
DR   PRO; PR:Q96LC7; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q96LC7; protein.
DR   Bgee; ENSG00000142512; Expressed in granulocyte and 136 other tissues.
DR   ExpressionAtlas; Q96LC7; baseline and differential.
DR   Genevisible; Q96LC7; HS.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0019902; F:phosphatase binding; IPI:UniProtKB.
DR   GO; GO:0042169; F:SH2 domain binding; IMP:UniProtKB.
DR   GO; GO:0033691; F:sialic acid binding; IBA:GO_Central.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0106015; P:negative regulation of inflammatory response to wounding; IPI:UniProtKB.
DR   Gene3D; 2.60.40.10; -; 4.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF13895; Ig_2; 1.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 4.
DR   SMART; SM00408; IGc2; 2.
DR   SUPFAM; SSF48726; SSF48726; 5.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   Adaptive immunity; Alternative splicing; Cell adhesion; Cell membrane;
KW   Disulfide bond; Glycoprotein; Immunity; Immunoglobulin domain;
KW   Innate immunity; Lectin; Membrane; Phosphoprotein; Reference proteome;
KW   Repeat; Secreted; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000255"
FT   CHAIN           17..697
FT                   /note="Sialic acid-binding Ig-like lectin 10"
FT                   /id="PRO_0000014950"
FT   TOPO_DOM        17..550
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        551..571
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        572..697
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          18..121
FT                   /note="Ig-like V-type"
FT   DOMAIN          146..231
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          251..339
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          344..441
FT                   /note="Ig-like C2-type 3"
FT   REGION          606..697
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           595..600
FT                   /note="ITIM motif 1"
FT   MOTIF           665..670
FT                   /note="ITIM motif 2"
FT   COMPBIAS        633..666
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         119
FT                   /ligand="N-acetylneuraminate"
FT                   /ligand_id="ChEBI:CHEBI:35418"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         667
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:12163025"
FT   CARBOHYD        100
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        355
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        364
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        486
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        504
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        36..173
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        41..101
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        164..215
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        276..323
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        380..425
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         125..214
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_002561"
FT   VAR_SEQ         140..185
FT                   /note="TALTQKPDVYIPETLEPGQPVTVICVFNWAFEECPPPSFSWTGAAL -> TG
FT                   MRWGGNPCLSHWGGTLGTAYGLSREGSQGPLQHKNLPPRSLSQP (in isoform
FT                   5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_002562"
FT   VAR_SEQ         141..198
FT                   /note="Missing (in isoform 3, isoform 6 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:12163025,
FT                   ECO:0000303|PubMed:12975309, ECO:0000303|PubMed:14702039"
FT                   /id="VSP_002564"
FT   VAR_SEQ         141..188
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045365"
FT   VAR_SEQ         146..228
FT                   /note="Missing (in isoform 9)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_045888"
FT   VAR_SEQ         186..697
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_002563"
FT   VAR_SEQ         252
FT                   /note="A -> D (in isoform 8)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_045853"
FT   VAR_SEQ         253..342
FT                   /note="Missing (in isoform 8)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_045854"
FT   VAR_SEQ         445..539
FT                   /note="Missing (in isoform 2, isoform 6, isoform 7, isoform
FT                   8 and isoform 9)"
FT                   /evidence="ECO:0000303|PubMed:11358961,
FT                   ECO:0000303|PubMed:12975309, ECO:0000303|PubMed:14702039"
FT                   /id="VSP_002565"
FT   VARIANT         226
FT                   /note="A -> V (in dbSNP:rs9304711)"
FT                   /evidence="ECO:0000269|PubMed:11284738,
FT                   ECO:0000269|PubMed:11358961, ECO:0000269|PubMed:12163025,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_019955"
FT   VARIANT         520
FT                   /note="R -> S (in dbSNP:rs1833785)"
FT                   /id="VAR_019956"
FT   MUTAGEN         119
FT                   /note="R->A: Disrupts interaction with CD24."
FT                   /evidence="ECO:0000269|PubMed:19264983"
FT   MUTAGEN         667
FT                   /note="Y->F: Abolishes binding to PTPN6."
FT                   /evidence="ECO:0000269|PubMed:12163025"
FT   CONFLICT        28
FT                   /note="S -> P (in Ref. 4; AAK51124)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        127
FT                   /note="R -> T (in Ref. 5; AAQ88703)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        134
FT                   /note="G -> R (in Ref. 4; AAK51124)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        268
FT                   /note="K -> R (in Ref. 6; AK303514)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        344
FT                   /note="P -> S (in Ref. 3; AAK92542)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        440
FT                   /note="L -> P (in Ref. 4; AAK51124)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        564
FT                   /note="L -> P (in Ref. 6; AK303514)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        587
FT                   /note="R -> K (in Ref. 3; AAK92542)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        624
FT                   /note="L -> P (in Ref. 5; AAQ88703)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        625
FT                   /note="P -> S (in Ref. 3; AAK92542)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   697 AA;  76592 MW;  E1B787F34CF7201A CRC64;
     MLLPLLLSSL LGGSQAMDGR FWIRVQESVM VPEGLCISVP CSFSYPRQDW TGSTPAYGYW
     FKAVTETTKG APVATNHQSR EVEMSTRGRF QLTGDPAKGN CSLVIRDAQM QDESQYFFRV
     ERGSYVRYNF MNDGFFLKVT ALTQKPDVYI PETLEPGQPV TVICVFNWAF EECPPPSFSW
     TGAALSSQGT KPTTSHFSVL SFTPRPQDHN TDLTCHVDFS RKGVSAQRTV RLRVAYAPRD
     LVISISRDNT PALEPQPQGN VPYLEAQKGQ FLRLLCAADS QPPATLSWVL QNRVLSSSHP
     WGPRPLGLEL PGVKAGDSGR YTCRAENRLG SQQRALDLSV QYPPENLRVM VSQANRTVLE
     NLGNGTSLPV LEGQSLCLVC VTHSSPPARL SWTQRGQVLS PSQPSDPGVL ELPRVQVEHE
     GEFTCHARHP LGSQHVSLSL SVHYSPKLLG PSCSWEAEGL HCSCSSQASP APSLRWWLGE
     ELLEGNSSQD SFEVTPSSAG PWANSSLSLH GGLSSGLRLR CEAWNVHGAQ SGSILQLPDK
     KGLISTAFSN GAFLGIGITA LLFLCLALII MKILPKRRTQ TETPRPRFSR HSTILDYINV
     VPTAGPLAQK RNQKATPNSP RTPLPPGAPS PESKKNQKKQ YQLPSFPEPK SSTQAPESQE
     SQEELHYATL NFPGVRPRPE ARMPKGTQAD YAEVKFQ
//
